BDPTD (BioAdaptives) Change In Payables And Accrued Expense : $0.05 Mil (TTM As of Sep. 2024)

View and export this data going back to 2014. Start your Free Trial

What is BioAdaptives Change In Payables And Accrued Expense?

BioAdaptives's Change In Payables And Accrued Expense for the quarter that ended in Sep. 2024 was $0.02 Mil. It means BioAdaptives's Accounts Payable & Accrued Expense increased by $0.02 Mil from Jun. 2024 to Sep. 2024 .

BioAdaptives's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was $0.04 Mil. It means BioAdaptives's Accounts Payable & Accrued Expense increased by $0.04 Mil from Dec. 2022 to Dec. 2023 .

BioAdaptives Change In Payables And Accrued Expense Historical Data

The historical data trend for BioAdaptives's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioAdaptives Change In Payables And Accrued Expense Chart

BioAdaptives Annual Data

Trend

Dec13

Dec14

Dec15

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

-0.02

0.06

0.23

0.19

0.04

BioAdaptives Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															0.01	0.01	0.01	0.01	0.02

BioAdaptives Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.05 Mil.

BioAdaptives Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of BioAdaptives's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

BioAdaptives Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » BioAdaptives Inc (OTCPK:BDPTD) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

2620 Regatta Drive, Suite 102, Las Vegas, NV, USA, 89128

Website

https://www.shopbioadaptives.com

BioAdaptives Inc is engaged in investigating, marketing and distributing natural plant- and algal-based products and medical devices that improve health and wellness for humans and animals, with an emphasis on pain relief, anti-viral function, and anti-aging properties. Its products include dietary supplements using natural ingredients and proprietary methods of optimizing the availability of nutrients in foods and beverages. The human products are designed to aid memory, cognition and focus; assist in sleep and fatigue reduction; provide pain relief and healing; and improve overall emotional and physical wellness. Its product lines include PluriPain, PrimiLungs, SleepEZ, MindNMemory, Cell Rejuven and ProteinNMore.

Executives

Richard Chiang	other: Previous Officer and Director	460 BRANNAN STREET SUITE 78064, SAN FRANCISCO CA 94107
Barry Epling	director	2251 NORTH RAMPART BLVD., #182, LAS VEGAS NV 89128
Ferris Holding Inc.	10 percent owner	2251 NORTH RAMPART BLVD., #182, LAS VEGAS NV 89128
Gerald Epling	director, officer: Pres, CEO, Secretary, CFO	2251 NORTH RAMPART BLVD., #182, LAS VEGAS NV 89128